BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33416253)

  • 1. Infliximab Drug-Induced Autoimmune Hepatitis in a Patient With Crohn's Ileocolitis.
    Karanfilian B; Mahpour N; Sarkar A
    Am J Ther; 2022 Nov-Dec 01; 29(6):e741-e743. PubMed ID: 33416253
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab.
    Cravo M; Silva R; Serrano M
    BioDrugs; 2010 Dec; 24 Suppl 1():25-7. PubMed ID: 21175232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune hepatitis during infliximab therapy for Crohn's disease: a case report.
    Doyle A; Forbes G; Kontorinis N
    J Crohns Colitis; 2011 Jun; 5(3):253-5. PubMed ID: 21575891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case.
    Goldfeld DA; Verna EC; Lefkowitch J; Swaminath A
    Dig Dis Sci; 2011 Nov; 56(11):3386-8. PubMed ID: 21597977
    [No Abstract]   [Full Text] [Related]  

  • 5. Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection.
    del Valle García-Sánchez M; Gómez-Camacho F; Poyato-González A; Iglesias-Flores EM; de Dios-Vega JF; Sancho-Zapatero R
    Inflamm Bowel Dis; 2004 Sep; 10(5):701-2. PubMed ID: 15472541
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe sarcoidosis-like reaction in a patient with Crohn's Disease treated with infliximab. Any relationship?
    Fuentes-Valenzuela E; Navarro Cañadas C; Oyarzún Bahamonde E; Moreta Rodriguez M; Barrio J
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101696. PubMed ID: 33852954
    [No Abstract]   [Full Text] [Related]  

  • 7. Posterior Reversible Encephalopathy Syndrome in a Patient With Crohn's Disease on Infliximab.
    Chow S; Patnana S; Gupta NK
    J Clin Gastroenterol; 2016 Sep; 50(8):687. PubMed ID: 27306938
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: treatment with subcutaneous CT-P13 in Crohn's disease patients with intravenous infliximab failure.
    Caron B; Fumery M; Netter P; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2022 Feb; 55(4):508-509. PubMed ID: 35092046
    [No Abstract]   [Full Text] [Related]  

  • 9. Infliximab induced liver injury in Crohn's disease: a challenging diagnosis.
    Carvalheiro J; Mendes S; Sofia C
    J Crohns Colitis; 2014 May; 8(5):436-7. PubMed ID: 24291019
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe anaphylactic reaction to infliximab in pediatric patients with Crohn's disease.
    Diamanti A; Castro M; Papadatou B; Ferretti F; Gambarara M
    J Pediatr; 2002 May; 140(5):636-7; author reply 637. PubMed ID: 12032538
    [No Abstract]   [Full Text] [Related]  

  • 11. Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B.
    Ueno Y; Tanaka S; Shimamoto M; Miyanaka Y; Hiyama T; Ito M; Kitadai Y; Yoshihara M; Sumii M; Chayama K
    Dig Dis Sci; 2005 Jan; 50(1):163-6. PubMed ID: 15712655
    [No Abstract]   [Full Text] [Related]  

  • 12. Babesiosis in a patient on infliximab for Crohn's disease.
    Cullen G; Sands BE; Yajnik V
    Inflamm Bowel Dis; 2010 Aug; 16(8):1269-70. PubMed ID: 19885904
    [No Abstract]   [Full Text] [Related]  

  • 13. [Listeria meningitis as complication of treatment with infliximab in a patient with Crohn's disease].
    Osuna Molina R; Ferrer Ríos T; Gallego Gallegos R; Ramos Lora M; Ynfante Ferrús M; Figueruela López B
    Rev Esp Enferm Dig; 2006 Jan; 98(1):60-1. PubMed ID: 16555939
    [No Abstract]   [Full Text] [Related]  

  • 14. Immortal time bias in estimates of mortality among infliximab-treated patients with Crohn's disease.
    Lewis JD
    Gut; 2010 Nov; 59(11):1586-7. PubMed ID: 20732919
    [No Abstract]   [Full Text] [Related]  

  • 15. Crohn's disease, infliximab and idiopathic thrombocytopenic purpura.
    Selby LA; Hess D; Shashidar H; de Villiers WJ; Selby LA
    Inflamm Bowel Dis; 2004 Sep; 10(5):698-700. PubMed ID: 15472539
    [No Abstract]   [Full Text] [Related]  

  • 16. Genital condylomata in a patient receiving infliximab for Crohn's disease.
    Somasekar A; Alcolado R
    Postgrad Med J; 2004 Jun; 80(944):358-9. PubMed ID: 15192172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy.
    Dubcenco E; Ottaway CA; Chen DL; Baker JP
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):565-6. PubMed ID: 16607158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial pneumonitis after infliximab therapy for Crohn's disease.
    Weatherhead M; Masson S; Bourke SJ; Gunn MC; Burns GP
    Inflamm Bowel Dis; 2006 May; 12(5):427-8. PubMed ID: 16670533
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab as first-line therapy for Crohn's disease is premature.
    Greenberg GR
    Inflamm Bowel Dis; 2002 Jan; 8(1):60-2; discussion 63-5. PubMed ID: 11837941
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab as first-line therapy for severe Crohn's disease?
    Cohen RD
    Inflamm Bowel Dis; 2002 Jan; 8(1):58-9; discussion 63-5. PubMed ID: 11837940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.